What is the current valuation of the US healthcare analytics market?

The market valuation was $4124.4 Million in 2024. Read More

What is the projected market size for the US healthcare analytics market by 2035?

The market is expected to reach $15811.0 Million by 2035. Read More

What is the expected CAGR for the US healthcare analytics market during the forecast period 2025 - 2035?

The expected CAGR is 12.99% during the forecast period. Read More

Which companies are considered key players in the US healthcare analytics market?

Key players include Optum, IBM, Cerner, McKesson, Allscripts, Philips, Epic Systems, Siemens Healthineers, and Cognizant. Read More

What are the main application segments in the US healthcare analytics market?

The main application segments include Predictive Analytics, Descriptive Analytics, Prescriptive Analytics, and Mobile Health Analytics. Read More

How did the predictive analytics segment perform in 2024?

The predictive analytics segment was valued at $1000.0 Million in 2024. Read More

What is the projected value of the cloud-based deployment mode by 2035?

The cloud-based deployment mode is projected to reach $7200.0 Million by 2035. Read More

What components are included in the US healthcare analytics market?

Components include Software, Hardware, and Services. Read More

What was the valuation of services in the US healthcare analytics market in 2024?

The services segment was valued at $2674.4 Million in 2024. Read More

Which use segment had the highest valuation in 2024?

The healthcare providers segment had the highest valuation at $1650.0 Million in 2024. Read More

US Healthcare Analytics Market

ID: MRFR/HC/14271-HCR

100 Pages

Rahul Gotadki

Last Updated: April 06, 2026

United States Healthcare Analytics Market Research Report: Size, Share, Trend Analysis - Growth Outlook & Industry Forecast 2025 To 2035

US Healthcare Analytics Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)12.99%

2024 Market Size$ 4,124.4 Million

2025 Market Size$ 4,660.16 Million

2035 Market Size$ 15,811 Million

Key Players

Optum

IBM

Cerner

McKesson

Allscripts

Philips

Trends

Increased Adoption of Predictive Analytics
Integration of Artificial Intelligence
Focus on Regulatory Compliance and Data Security

Opportunities

Expansion of Value-Based Care Models
Growing Emphasis on Patient Engagement
Rising Demand for Data-Driven Decision Making

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Application (USD Million)
  1. 4.1.1 Predictive Analytics
  2. 4.1.2 Descriptive Analytics
  3. 4.1.3 Prescriptive Analytics
  4. 4.1.4 Mobile Health Analytics
2. 4.2 Pharmaceutical, BY Deployment Mode (USD Million)
  1. 4.2.1 On-Premise
  2. 4.2.2 Cloud-Based
  3. 4.2.3 Hybrid
3. 4.3 Pharmaceutical, BY Component (USD Million)
  1. 4.3.1 Software
  2. 4.3.2 Hardware
  3. 4.3.3 Services
4. 4.4 Pharmaceutical, BY Use (USD Million)
  1. 4.4.1 Healthcare Providers
  2. 4.4.2 Payer Organizations
  3. 4.4.3 Pharmaceutical Companies
  4. 4.4.4 Research Institutions
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Optum (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 IBM (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Cerner (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 McKesson (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Allscripts (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Philips (NL)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Epic Systems (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Siemens Healthineers (DE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Cognizant (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY APPLICATION
3. 6.3 US MARKET ANALYSIS BY DEPLOYMENT MODE
4. 6.4 US MARKET ANALYSIS BY COMPONENT
5. 6.5 US MARKET ANALYSIS BY USE
6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
12. 6.12 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 PHARMACEUTICAL, BY DEPLOYMENT MODE, 2024 (% SHARE)
15. 6.15 PHARMACEUTICAL, BY DEPLOYMENT MODE, 2024 TO 2035 (USD Million)
16. 6.16 PHARMACEUTICAL, BY COMPONENT, 2024 (% SHARE)
17. 6.17 PHARMACEUTICAL, BY COMPONENT, 2024 TO 2035 (USD Million)
18. 6.18 PHARMACEUTICAL, BY USE, 2024 (% SHARE)
19. 6.19 PHARMACEUTICAL, BY USE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY DEPLOYMENT MODE, 2025-2035 (USD Million)
  3. 7.2.3 BY COMPONENT, 2025-2035 (USD Million)
  4. 7.2.4 BY USE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Pharmaceutical Market Segmentation

Pharmaceutical By Application (USD Million, 2025-2035)

Predictive Analytics
Descriptive Analytics
Prescriptive Analytics
Mobile Health Analytics

Pharmaceutical By Deployment Mode (USD Million, 2025-2035)

On-Premise
Cloud-Based
Hybrid

Pharmaceutical By Component (USD Million, 2025-2035)

Software
Hardware
Services

Pharmaceutical By Use (USD Million, 2025-2035)

US Healthcare Analytics Market Providers
Payer Organizations
Pharmaceutical Companies
Research Institutions

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”